Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão?

An introduction to the endocannabinoid system: from the early to the latest concepts

(2009) Luciano De Petrocellis et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors

(2009) Sudhir N. Umathe et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

(2009) J. Haller et al.   PSYCHOPHARMACOLOGY

The psychiatric side-effects of rimonabant

(2009) Fabrício A. Moreira et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

(2008) Roger G. Pertwee   ADDICTION BIOLOGY

The endocannabinoid system: emotion, learning and addiction

(2008) Fabrício A. Moreira et al.   ADDICTION BIOLOGY

Autonomic Neurotransmission: 60 Years Since Sir Henry Dale

(2008) Geoffrey Burnstock   Annual Review of Pharmacology and Toxicology

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

(2008) Rafael M. Bitencourt et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

(2008) Jonathan Z Long et al.   Nature Chemical Biology

Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

(2008) Vincenzo Micale et al.   NEUROPSYCHOPHARMACOLOGY

Listening to neuropeptides by microdialysis: Echoes and new sounds?

(2008) Carsten T. Wotjak et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?

(2008) F. A. Moreira et al.   NEURAL PLASTICITY

Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors

(2007) Fabricio A. Moreira et al.   NEUROPHARMACOLOGY